Shares of Xylem Inc. (NYSE:XYL - Get Free Report) have received an average rating of "Moderate Buy" from the ten analysts that are currently covering the stock, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $146.88.
Several analysts recently commented on XYL shares. Raymond James raised Xylem to a "hold" rating in a report on Thursday, May 15th. Citigroup lowered their price objective on Xylem from $152.00 to $134.00 and set a "buy" rating on the stock in a research report on Monday, April 14th. Royal Bank of Canada raised their price objective on shares of Xylem from $143.00 to $147.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 30th. Stifel Nicolaus boosted their target price on shares of Xylem from $140.00 to $141.00 and gave the company a "buy" rating in a research note on Wednesday, April 30th. Finally, Robert W. Baird dropped their price target on shares of Xylem from $149.00 to $146.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 30th.
Check Out Our Latest Analysis on Xylem
Xylem Stock Performance
Shares of XYL stock traded down $1.32 during trading hours on Monday, hitting $125.69. The company's stock had a trading volume of 1,226,682 shares, compared to its average volume of 1,414,474. The stock has a market cap of $30.59 billion, a PE ratio of 34.34, a price-to-earnings-growth ratio of 2.33 and a beta of 1.10. Xylem has a 12-month low of $100.47 and a 12-month high of $146.08. The company has a 50 day moving average of $117.41 and a 200 day moving average of $121.45. The company has a current ratio of 1.76, a quick ratio of 1.33 and a debt-to-equity ratio of 0.19.
Xylem (NYSE:XYL - Get Free Report) last posted its quarterly earnings results on Tuesday, April 29th. The industrial products company reported $1.03 EPS for the quarter, beating the consensus estimate of $0.95 by $0.08. The company had revenue of $2.07 billion for the quarter, compared to analyst estimates of $2.04 billion. Xylem had a net margin of 10.40% and a return on equity of 9.96%. The firm's revenue was up 1.8% on a year-over-year basis. During the same period in the prior year, the company earned $0.90 earnings per share. On average, sell-side analysts forecast that Xylem will post 4.65 EPS for the current fiscal year.
Xylem Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 26th. Shareholders of record on Thursday, May 29th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 1.27%. The ex-dividend date is Thursday, May 29th. Xylem's payout ratio is 43.01%.
Institutional Trading of Xylem
Institutional investors and hedge funds have recently modified their holdings of the stock. Impax Asset Management Group plc boosted its holdings in Xylem by 231.5% in the 4th quarter. Impax Asset Management Group plc now owns 5,561,661 shares of the industrial products company's stock worth $644,039,000 after buying an additional 3,883,845 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in shares of Xylem by 689.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company's stock valued at $443,074,000 after acquiring an additional 3,239,203 shares in the last quarter. Norges Bank acquired a new stake in shares of Xylem in the fourth quarter worth approximately $302,734,000. Northern Trust Corp increased its position in shares of Xylem by 42.0% during the fourth quarter. Northern Trust Corp now owns 3,268,433 shares of the industrial products company's stock worth $379,204,000 after purchasing an additional 966,399 shares in the last quarter. Finally, Nuveen LLC acquired a new position in Xylem in the 1st quarter valued at $99,726,000. Hedge funds and other institutional investors own 87.96% of the company's stock.
About Xylem
(
Get Free ReportXylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
See Also

Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.